Diastereoselection of enantiopure (S or R)-2-{(E)-(2-hydroxy-1-phenylethylimino)methyl}phenol (S- or R-HL1) with zinc(II)acetate leads to Δ-bis[(S)-2-{(E)-(2-hydroxy-1-phenylethylimino)methyl}phenoxide-κ2N,O]zinc(II) (Δ-Zn-S-L1) or Λ-bis[(R)-2-{(E)-(2-hydroxy-1-phenylethylimino)methyl}phenoxide-κ2N,O]zinc(II) (Λ-Zn-R-L1) as major products while racemic (R/S)-2-{(E)-(2-hydroxy-2-phenylethylimino)methyl}phenol (R/S-HL2) yields racemic Δ/Λ-bis[(R/S)-2-{(E)-(2-hydroxy-2-phenylethylimino)methyl}phenoxide-κ2N,O]zinc(II) (Δ/Λ-Zn-R/S-L2), respectively. The complexes are characterized by IR, UV–Vis, 1H NMR, mass spectrometry, circular dichroism (CD), and polarimetry. The bidentate N,O-chelation of two chiral enantiopure or racemic Schiff base ligands to four-coordinated, non-planar Zn(N^O)2 complexes leads to the preferential formation of one diastereomer or enantiomeric pair, respectively, in the solid state. Freshly prepared (30min) chloroform solutions from the solid product indicate a major diastereomeric component (ca. 67%) and a minor component (ca. 33%) by 1H NMR. The compound Zn-R/S-L2 crystallizes in the non-centrosymmetric polar space group Iba2 with formation of the enantiomeric pair Λ-Zn-S-L2 and Δ-Zn-R-L2 as a racemic mixture in the solid state. Time-dependent 1H NMR studies indicate that a single enantionmeric pair is still present in chloroform solution within 10min. In solution diastereomerization takes place, and the other diastereomers re-form within 40min (36h) to yield a diastereomeric ratio of 67:33% (54:46%) with the enantiomeric pair Λ-Zn-S-L2 and Δ-Zn-R-L2 as major diastereomers and Δ-Zn-S-L2 and Λ-Zn-R-L2 as minor diastereomers. The non-unity ratio of the different-energy enantiomeric pairs Λ-S/Δ-R (54%) versus Δ-S/Λ-R (46%) can be the basis for observed preferential crystallization of Λ-Zn-S-L2 and Δ-Zn-R-L2 with concomitant slow enantiomerization in solution as one component is removed from the solution equilibrium.
Read full abstract